174 related articles for article (PubMed ID: 37834182)
21. The immune potential of decidua-resident CD16
Zhang J; Lye SJ
Hum Immunol; 2021 May; 82(5):332-339. PubMed ID: 33583640
[TBL] [Abstract][Full Text] [Related]
22. Early Cytomegalovirus Reactivation and Expansion of CD56
Jang JE; Hwang DY; Chung H; Kim SJ; Eom JI; Jeung HK; Song J; Kim JS; Cheong JW; Min YH
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2070-2078. PubMed ID: 31212079
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterisation of transient receptor potential melastatin 2 and CD38 channels on natural killer cells using the novel application of flow cytometry.
Balinas C; Cabanas H; Staines D; Marshall-Gradisnik S
BMC Immunol; 2019 May; 20(1):14. PubMed ID: 31077146
[TBL] [Abstract][Full Text] [Related]
24. Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation.
Tanaka J; Sugita J; Asanuma S; Arita K; Shono Y; Kikutchi M; Shiratori S; Wakasa K; Yasumoto A; Shigematu A; Kondo T; Kobayashi T; Asaka M; Imamura M
Hum Immunol; 2009 Sep; 70(9):701-5. PubMed ID: 19524005
[TBL] [Abstract][Full Text] [Related]
25. Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development.
Domaica CI; Fuertes MB; Uriarte I; Girart MV; Sardañons J; Comas DI; Di Giovanni D; Gaillard MI; Bezrodnik L; Zwirner NW
PLoS One; 2012; 7(12):e51677. PubMed ID: 23240056
[TBL] [Abstract][Full Text] [Related]
26. Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125).
Belisle JA; Gubbels JA; Raphael CA; Migneault M; Rancourt C; Connor JP; Patankar MS
Immunology; 2007 Nov; 122(3):418-29. PubMed ID: 17617155
[TBL] [Abstract][Full Text] [Related]
27. A New Hope for CD56
Forconi CS; Oduor CI; Oluoch PO; Ong'echa JM; Münz C; Bailey JA; Moormann AM
Front Cell Infect Microbiol; 2020; 10():162. PubMed ID: 32373555
[TBL] [Abstract][Full Text] [Related]
28. Reduction of the CD16(-)CD56bright NK cell subset precedes NK cell dysfunction in prostate cancer.
Koo KC; Shim DH; Yang CM; Lee SB; Kim SM; Shin TY; Kim KH; Yoon HG; Rha KH; Lee JM; Hong SJ
PLoS One; 2013; 8(11):e78049. PubMed ID: 24223759
[TBL] [Abstract][Full Text] [Related]
29. CD56
Jaime P; García-Guerrero N; Estella R; Pardo J; García-Álvarez F; Martinez-Lostao L
Osteoarthritis Cartilage; 2017 Oct; 25(10):1708-1718. PubMed ID: 28668542
[TBL] [Abstract][Full Text] [Related]
30. Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults.
Lutz CT; Karapetyan A; Al-Attar A; Shelton BJ; Holt KJ; Tucker JH; Presnell SR
J Immunol; 2011 Apr; 186(8):4590-8. PubMed ID: 21402893
[TBL] [Abstract][Full Text] [Related]
31. CD33 Delineates Two Functionally Distinct NK Cell Populations Divergent in Cytokine Production and Antibody-Mediated Cellular Cytotoxicity.
Hejazi M; Zhang C; Bennstein SB; Balz V; Reusing SB; Quadflieg M; Hoerster K; Heinrichs S; Hanenberg H; Oberbeck S; Nitsche M; Cramer S; Pfeifer R; Oberoi P; Rühl H; Oldenburg J; Brossart P; Horn PA; Babor F; Wels WS; Fischer JC; Möker N; Uhrberg M
Front Immunol; 2021; 12():798087. PubMed ID: 35058934
[TBL] [Abstract][Full Text] [Related]
32. CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation.
Morandi F; Horenstein AL; Chillemi A; Quarona V; Chiesa S; Imperatori A; Zanellato S; Mortara L; Gattorno M; Pistoia V; Malavasi F
J Immunol; 2015 Aug; 195(3):965-72. PubMed ID: 26091716
[TBL] [Abstract][Full Text] [Related]
33. Loss of CCR7 expression on CD56(bright) NK cells is associated with a CD56(dim)CD16⁺ NK cell-like phenotype and correlates with HIV viral load.
Hong HS; Ahmad F; Eberhard JM; Bhatnagar N; Bollmann BA; Keudel P; Ballmaier M; Zielinska-Skowronek M; Schmidt RE; Meyer-Olson D
PLoS One; 2012; 7(9):e44820. PubMed ID: 23028633
[TBL] [Abstract][Full Text] [Related]
34. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.
Romagnani C; Juelke K; Falco M; Morandi B; D'Agostino A; Costa R; Ratto G; Forte G; Carrega P; Lui G; Conte R; Strowig T; Moretta A; Münz C; Thiel A; Moretta L; Ferlazzo G
J Immunol; 2007 Apr; 178(8):4947-55. PubMed ID: 17404276
[TBL] [Abstract][Full Text] [Related]
35. The biology of human natural killer-cell subsets.
Cooper MA; Fehniger TA; Caligiuri MA
Trends Immunol; 2001 Nov; 22(11):633-40. PubMed ID: 11698225
[TBL] [Abstract][Full Text] [Related]
36. Role of chemokines in the biology of natural killer cells.
Maghazachi AA
Curr Top Microbiol Immunol; 2010; 341():37-58. PubMed ID: 20369317
[TBL] [Abstract][Full Text] [Related]
37. CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection.
Reeves RK; Gillis J; Wong FE; Yu Y; Connole M; Johnson RP
Blood; 2010 Jun; 115(22):4439-46. PubMed ID: 20339088
[TBL] [Abstract][Full Text] [Related]
38. Activation status of CD56
Liu M; Liu J; Zhang X; Xiao Y; Jiang G; Huang X
Clin Rheumatol; 2021 Mar; 40(3):1103-1112. PubMed ID: 32797360
[TBL] [Abstract][Full Text] [Related]
39. Selective downregulation of natural killer activating receptors on NK cells and upregulation of PD-1 expression on T cells in children with severe and/or recurrent Herpes simplex virus infections.
Lenart M; Kluczewska A; Szaflarska A; Rutkowska-Zapała M; Wąsik M; Ziemiańska-Pięta A; Kobylarz K; Pituch-Noworolska A; Siedlar M
Immunobiology; 2021 May; 226(3):152097. PubMed ID: 34015527
[TBL] [Abstract][Full Text] [Related]
40. Peripheral natural killer cytotoxicity and CD56(pos)CD16(pos) cells increase during early pregnancy in women with a history of recurrent spontaneous abortion.
Emmer PM; Nelen WL; Steegers EA; Hendriks JC; Veerhoek M; Joosten I
Hum Reprod; 2000 May; 15(5):1163-9. PubMed ID: 10783371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
